These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26457987)

  • 21. PDCD6 is an independent predictor of progression free survival in epithelial ovarian cancer.
    Su D; Xu H; Feng J; Gao Y; Gu L; Ying L; Katsaros D; Yu H; Xu S; Qi M
    J Transl Med; 2012 Feb; 10():31. PubMed ID: 22369209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer.
    Qiu JJ; Lin YY; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
    Gynecol Oncol; 2014 Jul; 134(1):121-8. PubMed ID: 24662839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition.
    Long H; Xiang T; Qi W; Huang J; Chen J; He L; Liang Z; Guo B; Li Y; Xie R; Zhu B
    Oncotarget; 2015 Mar; 6(8):5846-59. PubMed ID: 25788271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-99a suppressed cell proliferation and invasion by directly targeting HOXA1 through regulation of the AKT/mTOR signaling pathway and EMT in ovarian cancer.
    Zhang L; Liu XL; Yuan Z; Cui J; Zhang H
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4663-4672. PubMed ID: 31210292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basigin-2 is the predominant basigin isoform that promotes tumor cell migration and invasion and correlates with poor prognosis in epithelial ovarian cancer.
    Zhao SH; Wang Y; Wen L; Zhai ZB; Ai ZH; Yao NL; Wang L; Liu WC; Chen BL; Li Y; Yang H
    J Transl Med; 2013 Apr; 11():92. PubMed ID: 23566400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophage-derived CCL18 promotes osteosarcoma proliferation and migration by upregulating the expression of UCA1.
    Su Y; Zhou Y; Sun YJ; Wang YL; Yin JY; Huang YJ; Zhang JJ; He AN; Han K; Zhang HZ; Yao Y; Lv XB; Hu HY
    J Mol Med (Berl); 2019 Jan; 97(1):49-61. PubMed ID: 30426155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer.
    Xu JH; Wang Y; Xu D
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3225-3234. PubMed ID: 31081074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis.
    Lin X; Chen L; Yao Y; Zhao R; Cui X; Chen J; Hou K; Zhang M; Su F; Chen J; Song E
    Oncotarget; 2015 Aug; 6(24):20485-99. PubMed ID: 26244871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis.
    Zhao L; Ji G; Le X; Luo Z; Wang C; Feng M; Xu L; Zhang Y; Lau WB; Lau B; Yang Y; Lei L; Yang H; Xuan Y; Chen Y; Deng X; Yi T; Yao S; Zhao X; Wei Y; Zhou S
    Oncogene; 2017 Jun; 36(24):3384-3396. PubMed ID: 28114283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual Targeting of mTOR Activity with Torin2 Potentiates Anticancer Effects of Cisplatin in Epithelial Ovarian Cancer.
    Hussain AR; Al-Romaizan M; Ahmed M; Thangavel S; Al-Dayel F; Beg S; Uddin S; Siraj AK; Al-Kuraya KS
    Mol Med; 2015 May; 21(1):466-78. PubMed ID: 26023849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-137 suppresses tumor growth in epithelial ovarian cancer in vitro and in vivo.
    Zhang L; Li Z; Gai F; Wang Y
    Mol Med Rep; 2015 Aug; 12(2):3107-14. PubMed ID: 25955305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer.
    Huang B; Yin M; Li X; Cao G; Qi J; Lou G; Sheng S; Kou J; Chen K; Yu B
    Oncotarget; 2016 May; 7(19):27552-66. PubMed ID: 27050277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxia inducible factor 1α-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer.
    Ji F; Wang Y; Qiu L; Li S; Zhu J; Liang Z; Wan Y; Di W
    Int J Oncol; 2013 May; 42(5):1578-88. PubMed ID: 23545606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of matrix metalloproteinase 9 by small interfering RNA inhibits the tumor growth of ovarian epithelial carcinoma in vitro and in vivo.
    Guo F; Tian J; Cui M; Fang M; Yang L
    Mol Med Rep; 2015 Jul; 12(1):753-9. PubMed ID: 25738807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
    Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
    Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of serum CCL18 as a potential biomarker for ovarian cancer.
    Yuan L; Wan J; Huang C; Liang J; Liu M; Yue C; Li L
    Cancer Biomark; 2017 Dec; 21(1):97-104. PubMed ID: 29036787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactive oxygen species promote ovarian cancer progression via the HIF-1α/LOX/E-cadherin pathway.
    Wang Y; Ma J; Shen H; Wang C; Sun Y; Howell SB; Lin X
    Oncol Rep; 2014 Nov; 32(5):2150-8. PubMed ID: 25174950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nesfatin-1 inhibits ovarian epithelial carcinoma cell proliferation in vitro.
    Xu Y; Pang X; Dong M; Wen F; Zhang Y
    Biochem Biophys Res Commun; 2013 Nov; 440(4):467-72. PubMed ID: 23764403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human epithelial-type ovarian tumour marker beta-2-microglobulin is regulated by the TGF-β signaling pathway.
    Sun W; Gui L; Zuo X; Zhang L; Zhou D; Duan X; Ren W; Xu G
    J Transl Med; 2016 Mar; 14():75. PubMed ID: 26983758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis.
    Hou M; Cheng Z; Shen H; He S; Li Y; Pan Y; Feng C; Chen X; Zhang Y; Lin M; Wang L; Ke Z
    Oncotarget; 2015 Nov; 6(34):35813-29. PubMed ID: 26452130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.